General form of registration statement for all companies including face-amount certificate companies

Intangible Assets (Details Narrative)

v3.20.2
Intangible Assets (Details Narrative) - USD ($)
6 Months Ended 12 Months Ended
Jun. 30, 2020
Jun. 30, 2019
Dec. 31, 2019
Dec. 31, 2018
Mar. 19, 2018
Amortization expense $ 397,664 $ 397,664 $ 795,328 $ 621,647  
Future amortization expense, year one 795,000        
Future amortization expense, year two $ 788,000        
CoNCERT Pharmaceuticals, Inc [Member]          
Recognition of deferred tax liability         $ 3,037,147
Intangible asset, tax basis         1,782
CoNCERT Pharmaceuticals, Inc [Member] | License Rights [Member]          
Purchase price         8,000,000
Transaction cost         1,782
Recognition of deferred tax liability         3,037,147
Intangible asset, tax basis         $ 1,782